<?xml version="1.0" encoding="UTF-8"?>
<p id="para0023">In rare cases, SARS-CoV-2 has been detected in blood, but there are no reports of transmission from donor products [
 <xref rid="bib0023" ref-type="bibr">23</xref>,
 <xref rid="bib0024" ref-type="bibr">24</xref>]. According to the FDA, no confirmed or suspected cases of transfusion-transmitted COVID-19 have been reported to date. Current American Association of Blood Banks guidelines do not recommend universal screening for SARS-CoV-2 in blood products, and current FDA guidelines recommend considering the donor's infection and exposure history in the 28 days before donation [
 <xref rid="bib0025" ref-type="bibr">25</xref>,
 <xref rid="bib0026" ref-type="bibr">26</xref>]. The National Marrow Donor Program/Be The Match has already implemented a donor screening questionnaire 
 <xref rid="bib0027" ref-type="bibr">[27]</xref>. The World Marrow Donor Association has also produced recommendations and we endorse those guidelines (
 <xref rid="tbl0002" ref-type="table">Table 2</xref> ). Within 28 days before donation, donors should avoid any contact with individuals with a syndrome suggestive of COVID-19, crowded places, and large gatherings.
</p>
